Actonel
NDC 0430-0478, Risedronate Sodium, tablet, film coated, from Allergan, Inc..
- Product NDC
- 0430-0478
- Status
- Listed
- Labeler
- Allergan, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020835
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0430-0478 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RISEDRONATE SODIUM HEMIPENTAHYDRATE129 mg/1
- RISEDRONATE SODIUM MONOHYDRATE21 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Bisphosphonate [EPC]; Diphosphonates [CS]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0430-0478-01 | 00430047801 | 1 TABLET, FILM COATED in 1 DOSE PACK (0430-0478-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/24ed00e0-25e2-49a8-97fc-66c1b417dc0b
Use it
Look up 0430-0478 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0430-0478 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0430-0478. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.